Thursday, June 19, 2008 11:14:18 AM
Hepalife,(HPLF), has been touting the importance of this conference for weeks...to debut their artificial liver reactor therapy...interesting that BIPH chose to announce their Myo-Vad animal test results a few hours before the conference begins...especially with the improved diastolic performance data...JMHO
The FDA should fast track this technology to help save the lives of sudden cardiac arrest patients...now...how many must die needlessly while they procrastinate?
expecting the unexpected...sooner than later...Go Dallas...
ole bub and the dawgs
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM